VenoStent
YC S20Houston, US · Founded 2017 · 17 employees · 3 known investors
SelfWrap develops bioabsorbable wrap materials for vascular grafts that conform to individual patient anatomy and are designed to be absorbed by the body, unlike alloy-based alternatives. The company is developing the product for coronary and peripheral bypass grafting applications.
Founders & leadership· Y Combinator alumni (S20)
Geoffrey LucksinFounder
Investors · 3
In the news
- VenoStent Completes $16M Series A Financing, Receives IDE Approval from FDA to Begin US Trialfinance.yahoo.com · 2023
- VenoStent Technology Receives Breakthrough Device Designation by FDA | BioSpacebiospace.com · 2022